Phathom Pharmaceuticals, Inc.
2022 Q1 - 2026 Q1 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 138,503 | 3.6% | 12,466,489 | 3/31/2026 |
| 2025 Q4 | 2/13/2026 | 206,819 | 5.6% | 12,466,489 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 146,731 | 4.4% | 12,466,489 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 119,554 | 4.8% | 12,466,489 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 63,385 | 2.9% | 10,109,279 | 3/31/2025 |
| 2024 Q4 | 2/18/2025 | 82,087 | 3.4% | 10,109,279 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 182,776 | 7.3% | 10,109,279 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 104,126 | 4.9% | 10,109,279 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 107,361 | 4.5% | 10,109,279 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 92,298 | 4.9% | 10,109,279 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 104,833 | 7.0% | 10,109,279 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 144,765 | 8.6% | 10,109,279 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 60,027 | 4.3% | 8,407,152 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 94,328 | 5.9% | 8,407,152 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 93,151 | 7.2% | 8,407,152 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 49,183 | 4.6% | 5,827,415 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 79,311 | 6.8% | 5,827,415 | 3/31/2022 |